|
DPH5 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.639200E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.624800E-01 |
| Normal-vs-Stage2 |
7.807800E-01 |
| Normal-vs-Stage3 |
1.105370E-01 |
| Normal-vs-Stage4 |
1.753380E-01 |
| Stage1-vs-Stage2 |
4.427200E-01 |
| Stage1-vs-Stage3 |
1.252090E-02 |
| Stage1-vs-Stage4 |
3.203600E-02 |
| Stage2-vs-Stage3 |
4.328600E-01 |
| Stage2-vs-Stage4 |
4.886800E-01 |
| Stage3-vs-Stage4 |
9.709000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.455200E-01 |
| Normal-vs-AfricanAmerican |
4.850400E-01 |
| Normal-vs-Asian |
4.805400E-01 |
| Caucasian-vs-AfricanAmerican |
6.276000E-01 |
| Caucasian-vs-Asian |
3.891200E-01 |
| AfricanAmerican-vs-Asian |
3.317200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.848000E-01 |
| Normal-vs-Female |
8.786600E-01 |
| Male-vs-Female |
3.777000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.708600E-01 |
| Normal-vs-Age(41-60Yrs) |
2.462200E-01 |
| Normal-vs-Age(61-80Yrs) |
4.992000E-01 |
| Normal-vs-Age(81-100Yrs) |
3.739500E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.574600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.954600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.931600E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.251500E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.479700E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.895600E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
6.678600E-01 |
| Normal-vs-Grade 2 |
8.450500E-02 |
| Normal-vs-Grade 3 |
1.619250E-01 |
| Normal-vs-Grade 4 |
2.094100E-02 |
| Grade 1-vs-Grade 2 |
3.205600E-01 |
| Grade 1-vs-Grade 3 |
9.066400E-01 |
| Grade 1-vs-Grade 4 |
4.750400E-01 |
| Grade 2-vs-Grade 3 |
1.880270E-03 |
| Grade 2-vs-Grade 4 |
3.802300E-04 |
| Grade 3-vs-Grade 4 |
2.233600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.999740E-02 |
| Normal-vs-ccB subtype |
1.684060E-02 |
| ccA subtype-vs-ccB subtype |
3.05219999996442E-06 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.683600E-01 |
| Normal-vs-N1 |
1.669390E-01 |
| N0-vs-N1 |
1.300370E-01 |
|
|
